ArticleInternational journal of biological sciences2022

HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer.

Zhiyuan Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.